References
- Jonsson RH, Haga J, Gordon TP. Sjogren's syndrome. In: Koopman WJ, editor. Arthritis, allied conditions-a textbook of rheumatology, vol 2, 14th edn. Philadelphia: Lippincott Williams & Wilkins; 2001.
- Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004; 164(12):1275–84.
- Tonami H, Matoba M, Kuginuki Y, Yokota H, Higashi K, Yamamoto I, et al. Clinical and imaging findings of lymphoma in patients with Sjogren syndrome. J Comput Assist Tomogr. 2003;27:517–24.
- Garcia-Carrasco M, Ramos-Casals M, Cervera R, Font J. Primary Sjogren's syndrome and lymphatic proliferation. Med Clin (Bare). 2000;114:740–6.
- Ramos-Casals M, Font J, Garcia-Canasco M, Brito MP, Rosas J, Calvo-Alen J, et al. Primary Sjogren syndrome: hematologic pat-terns of disease expression. Medicine (Baltimore). 2002;81:281–92.
- Masaki Y, Sugai S. Lymphoprofiferative disorders in Sjogren's syndrome. Autoimmun Rev. 2004;3:175–82.
- Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol. 2006;18:129–34.
- Fox RI. Sjogren's syndrome. Lancet. 2005;366:321–31.
- Nagai M, Sasaki K, Tokuda M, Tasaka T, Goto T, Ohnishi M, et al. Hodgkin's disease and Sjogren's syndrome. Eur J Haematol. 1993;50:180–2.
- Martin-Santos JM, Canetero L, Armentia A, Alonso E, Gil I. Hodgkin's disease occurring in primary Sjogren's syndrome. Ann Rheum Dis. 1990;49:646–7.
- Vivancos J, Bosch X, Grau JM, Coca A, Font J. Development of Hodgkin's disease in the course of primary Sjogren's syndrome. Br J Rheumatol. 1992;31:561-3 (Erratum in Br J Rheumatol 1993;32: 157).
- Navarro B, Yebra M, Romero J, Suarez-Massa D. Hodgkin lymphoma associated with primary Sjogren's syndrome. Med Clin (Barc). 2001;116:636.
- Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann ML. Biology of Hodgkin's lymphoma. Ann Oncol. 2002;13[Suppl 11:11–8.
- Rubin P, Holt JF. Secretory sialography in diseases of the major salivary glands. Am J Roentgenol Radium Ther Nucl Med. 1957;77:575–98.
- Rothman S, Block M, Hauser FV. Sjogren's syndrome associated with lymphoblastoma and hypersplenism. Arch Derm Syphilol. 1951;63:642.
- Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum. 2002;46:741–7.
- Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, et al. Immune-related conditions and immune-modulating medi-cations as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol. 2005;162:1153–61.
- Anderson LG, Talal N. The spectrum of benign to malignant lymphoprofiferation in Sjogren's syndrome. Clin Exp Immunol. 1972;10:199–221.
- Zulman J, Jaffe R, Talal N. Evidence that the malignant lym-phoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med. 1978;299:1215–20.
- Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alex-ander EL, Carsons SE. Classification criteria for Sjogren's syndrome: a revised version of European criteria proposed by the America-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.